Salvianolic acid B ameliorates neuroinflammation and neuronal injury via blocking NLRP3 inflammasome and promoting SIRT1 in experimental subarachnoid hemorrhage

The nucleotide-binding oligomerization domain (NOD)-like receptor family pyrin domain containing 3 (NLRP3) inflammasome-mediated immuno-inflammatory response plays a critical role in exacerbating early brain injury (EBI) after subarachnoid hemorrhage (SAH). Salvianolic acid B (SalB) has previously b...

Full description

Bibliographic Details
Main Authors: Dayong Xia, Jinlong Yuan, Degang Wu, Haibin Dai, Zong Zhuang
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-07-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1159958/full
_version_ 1827892990200250368
author Dayong Xia
Jinlong Yuan
Degang Wu
Haibin Dai
Zong Zhuang
author_facet Dayong Xia
Jinlong Yuan
Degang Wu
Haibin Dai
Zong Zhuang
author_sort Dayong Xia
collection DOAJ
description The nucleotide-binding oligomerization domain (NOD)-like receptor family pyrin domain containing 3 (NLRP3) inflammasome-mediated immuno-inflammatory response plays a critical role in exacerbating early brain injury (EBI) after subarachnoid hemorrhage (SAH). Salvianolic acid B (SalB) has previously been shown to suppress neuroinflammatory responses in many disorders. Meanwhile, a previous study has demonstrated that SalB mitigated oxidative damage and neuronal degeneration in a prechiasmatic injection model of SAH. However, the therapeutic potential of SalB on immuno-inflammatory responses after SAH remains unclear. In the present study, we explored the therapeutic effects of SalB on neuroinflammatory responses in an endovascular perforation SAH model. We observed that SalB ameliorated SAH-induced functional deficits. Additionally, SalB significantly mitigated microglial activation, pro-inflammatory cytokines release, and neuronal injury. Mechanistically, SalB inhibited NLRP3 inflammasome activation and increased sirtuin 1 (SIRT1) expression after SAH. Administration of EX527, an inhibitor of SIRT1, abrogated the anti-inflammatory effects of SalB against SAH and further induced NLRP3 inflammasome activation. In contrast, MCC950, a potent and selective NLRP3 inflammasome inhibitor, reversed the detrimental effects of SIRT1 inhibition by EX527 on EBI. These results indicated that SalB effectively repressed neuroinflammatory responses and neuronal damage after SAH. The action of SalB appeared to be mediated by blocking NLRP3 inflammasome and promoting SIRT1 signaling.
first_indexed 2024-03-12T21:47:50Z
format Article
id doaj.art-ff9aebfb9dc54faa9d2833831884206a
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-03-12T21:47:50Z
publishDate 2023-07-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-ff9aebfb9dc54faa9d2833831884206a2023-07-26T09:44:12ZengFrontiers Media S.A.Frontiers in Immunology1664-32242023-07-011410.3389/fimmu.2023.11599581159958Salvianolic acid B ameliorates neuroinflammation and neuronal injury via blocking NLRP3 inflammasome and promoting SIRT1 in experimental subarachnoid hemorrhageDayong Xia0Jinlong Yuan1Degang Wu2Haibin Dai3Zong Zhuang4The Translational Research Institute for Neurological Disorders of Wannan Medical College, Department of Neurosurgery, the First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College), Wuhu, ChinaThe Translational Research Institute for Neurological Disorders of Wannan Medical College, Department of Neurosurgery, the First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College), Wuhu, ChinaThe Translational Research Institute for Neurological Disorders of Wannan Medical College, Department of Neurosurgery, the First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College), Wuhu, ChinaDepartment of Neurosurgery, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, ChinaDepartment of Neurosurgery, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, ChinaThe nucleotide-binding oligomerization domain (NOD)-like receptor family pyrin domain containing 3 (NLRP3) inflammasome-mediated immuno-inflammatory response plays a critical role in exacerbating early brain injury (EBI) after subarachnoid hemorrhage (SAH). Salvianolic acid B (SalB) has previously been shown to suppress neuroinflammatory responses in many disorders. Meanwhile, a previous study has demonstrated that SalB mitigated oxidative damage and neuronal degeneration in a prechiasmatic injection model of SAH. However, the therapeutic potential of SalB on immuno-inflammatory responses after SAH remains unclear. In the present study, we explored the therapeutic effects of SalB on neuroinflammatory responses in an endovascular perforation SAH model. We observed that SalB ameliorated SAH-induced functional deficits. Additionally, SalB significantly mitigated microglial activation, pro-inflammatory cytokines release, and neuronal injury. Mechanistically, SalB inhibited NLRP3 inflammasome activation and increased sirtuin 1 (SIRT1) expression after SAH. Administration of EX527, an inhibitor of SIRT1, abrogated the anti-inflammatory effects of SalB against SAH and further induced NLRP3 inflammasome activation. In contrast, MCC950, a potent and selective NLRP3 inflammasome inhibitor, reversed the detrimental effects of SIRT1 inhibition by EX527 on EBI. These results indicated that SalB effectively repressed neuroinflammatory responses and neuronal damage after SAH. The action of SalB appeared to be mediated by blocking NLRP3 inflammasome and promoting SIRT1 signaling.https://www.frontiersin.org/articles/10.3389/fimmu.2023.1159958/fullNLRP3salvianolic acid Bsubarachnoid hemorrhagesirtuin 1MCC950
spellingShingle Dayong Xia
Jinlong Yuan
Degang Wu
Haibin Dai
Zong Zhuang
Salvianolic acid B ameliorates neuroinflammation and neuronal injury via blocking NLRP3 inflammasome and promoting SIRT1 in experimental subarachnoid hemorrhage
Frontiers in Immunology
NLRP3
salvianolic acid B
subarachnoid hemorrhage
sirtuin 1
MCC950
title Salvianolic acid B ameliorates neuroinflammation and neuronal injury via blocking NLRP3 inflammasome and promoting SIRT1 in experimental subarachnoid hemorrhage
title_full Salvianolic acid B ameliorates neuroinflammation and neuronal injury via blocking NLRP3 inflammasome and promoting SIRT1 in experimental subarachnoid hemorrhage
title_fullStr Salvianolic acid B ameliorates neuroinflammation and neuronal injury via blocking NLRP3 inflammasome and promoting SIRT1 in experimental subarachnoid hemorrhage
title_full_unstemmed Salvianolic acid B ameliorates neuroinflammation and neuronal injury via blocking NLRP3 inflammasome and promoting SIRT1 in experimental subarachnoid hemorrhage
title_short Salvianolic acid B ameliorates neuroinflammation and neuronal injury via blocking NLRP3 inflammasome and promoting SIRT1 in experimental subarachnoid hemorrhage
title_sort salvianolic acid b ameliorates neuroinflammation and neuronal injury via blocking nlrp3 inflammasome and promoting sirt1 in experimental subarachnoid hemorrhage
topic NLRP3
salvianolic acid B
subarachnoid hemorrhage
sirtuin 1
MCC950
url https://www.frontiersin.org/articles/10.3389/fimmu.2023.1159958/full
work_keys_str_mv AT dayongxia salvianolicacidbamelioratesneuroinflammationandneuronalinjuryviablockingnlrp3inflammasomeandpromotingsirt1inexperimentalsubarachnoidhemorrhage
AT jinlongyuan salvianolicacidbamelioratesneuroinflammationandneuronalinjuryviablockingnlrp3inflammasomeandpromotingsirt1inexperimentalsubarachnoidhemorrhage
AT degangwu salvianolicacidbamelioratesneuroinflammationandneuronalinjuryviablockingnlrp3inflammasomeandpromotingsirt1inexperimentalsubarachnoidhemorrhage
AT haibindai salvianolicacidbamelioratesneuroinflammationandneuronalinjuryviablockingnlrp3inflammasomeandpromotingsirt1inexperimentalsubarachnoidhemorrhage
AT zongzhuang salvianolicacidbamelioratesneuroinflammationandneuronalinjuryviablockingnlrp3inflammasomeandpromotingsirt1inexperimentalsubarachnoidhemorrhage